Plegridy two year data confirms safety and efficacy in MS

A board to discuss the Multiple Sclerosis modifying drug Plegridy

Plegridy two year data confirms safety and efficacy in MS

Postby MSUK » Thu Sep 11, 2014 5:24 am

Plegridy two year data confirms safety and efficacy in MS patients

Biogen Idec today announced new data from the second year of its Phase 3 ADVANCE clinical trial that show the positive treatment effects of Plegridy™ (peginterferon beta-1a) were maintained in people with relapsing forms of multiple sclerosis (RMS) beyond the first year of the study. These results were presented at the sixth Triennial Joint Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS) in Boston.... Read More - http://www.ms-uk.org/plegridy
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2876
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Plegridy

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service